Armistice Capital’s Inhibikase Therapeutics IKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$814K Buy
2024
Q2
$713K Buy
2023
Q4
Sell
2023
Q3
$259K Sell
2023
Q2
$1.79M Buy
2023
Q1
$1.95M Buy